Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-10 6:16 pm Sale | 2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | Renaissance Technologies LLC | 0 0.000% | -1,636,966 (Position Closed) | Filing History |
| 2021-02-10 11:14 am Sale | 2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | The Vanguard Group | 2,338,657 9.070% | -178,074 (-7.08%) | Filing History |
| 2021-02-09 3:06 pm Purchase | 2021-02-09 | 13G | Ligand Pharmaceuticals Incorporated LGND | Wasatch Advisors LP | 1,873,902 7.300% | 1,873,902 (New Position) | Filing History |
| 2021-02-08 5:19 pm Sale | 2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | BANK OF AMERICA CORP BAC | 339,280 1.300% | -1,326,529 (-79.63%) | Filing History |
| 2021-01-26 6:52 pm Sale | 2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | BlackRock Inc. BLK | 3,151,492 12.200% | -671,917 (-17.57%) | Filing History |
| 2021-01-15 4:11 pm Unchanged | 2020-12-31 | 13G | Seelos Therapeutics, Inc. SEEL | LIGAND PHARMACEUTICALS INC LGND | 579 4.100% | 0 (Unchanged) | Filing History |